A Foreign Play On The U.S. Election
Numerous post-election investment ideas have been bandied about – including Treasuries and domestic bank and healthcare stocks. Here’s why one of the best ways to… Read More »A Foreign Play On The U.S. Election
Numerous post-election investment ideas have been bandied about – including Treasuries and domestic bank and healthcare stocks. Here’s why one of the best ways to… Read More »A Foreign Play On The U.S. Election
In the final weeks of 2018 (and the final weeks of a GOP-controlled House of Representatives), there are a number of potential legislative catalysts for… Read More »Tis The Season For Potential Health Care Catalysts
This biotech company’s drug for treating hypoactive sexual desire disorder in women is expected to receive FDA approval in early January 2019. With increasing market… Read More »The New – And More Effective – Female Viagra: An Attractive Opportunity?
With the global market for wearable medical devices projected to surpass $12 billion by 2021, healthcare is poised to be “the next most happening growth… Read More »Wearables: Tech Stocks’ Next Growth Frontier
The FDA just approved a first-of-its-kind vaginal birth control system that is woman-controlled, procedure-free, long-acting and reversible. Here is the company behind this “new chemical… Read More »The New Birth Control System That Could Shake Up The Contraceptives Market
With healthcare ETFs displaying positive momentum (and a plethora of reasons to believe that this momentum will continue), this triple-leveraged healthcare ETF could be an… Read More »A Triple Dose Of Healthcare Momentum
Among small-cap stocks – which have been robustly outperforming their large-cap counterparts this year – healthcare small-caps have been the most impressive performers. Which healthcare… Read More »Bargain Hunting In Declining Health
As the second-quarter earnings season gets underway, these three healthcare stocks – including a biotech that now has a near monopoly on the cystic fibrosis… Read More »Tip Top Healthcare Bets From Top Analysts
This women-focused medical device stock – the author’s favorite speculative stock for 2018 – has had an impressive run so far this year. Here are… Read More »Healthy Speculation
These three stocks – including a clinical-stage biotech with a still-promising drug candidate – may be under-performing at the moment, but some of Wall Street’s… Read More »Bargain Bin & Analyst Adored